Zhiwen Zheng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Zhiwen Zheng has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Changwen Zhang
Department of Urology, Tianjin Institute of Urology, the Second Hospital of Tianjin Medical University
1 shared publication - Chunlei Ma
Department of Urology, Tianjin 4th Center Hospital, The 4th Center Clinical College of Tianjin Medical University, Tianjin, China
1 shared publication Hang Qi
State Key Laboratory of Precision Measuring Technology & Instruments, School of Precision Instrument and Opto-electronics Engineering, Tianjin University, Tianjin, 300072, China
1 shared publication- Jianqiang Zhu
Department of Urology, Tianjin Institute of Urology, The second hospital of Tianjin Medical University, Tianjin, China
1 shared publication - Jianxi Shi
Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China
1 shared publication - Leyi Liu
Department of Urology, Tianjin Institute of Urology, The second Hospital of Tianjin Medical University, Tianjin 300211, China
1 shared publication
Latest Publications
- 22 June 2024
- Published by Elsevier in Analytica Chimica Acta
- Vol. 1317, 342899
Machine learning assisted microfluidics dual fluorescence flow cytometry for detecting bladder tumor cells based on morphological characteristic parameters
- 22 June 2024
- Published by Elsevier in Analytica Chimica Acta
- Vol. 1317, 342899
Machine learning assisted microfluidics dual fluorescence flow cytometry for detecting bladder tumor cells based on morphological characteristic parameters
- 8 August 2023
- Published by Elsevier in Chemosphere
- Vol. 339, 139716
Low-dose antimony exposure promotes prostate cancer proliferation by inhibiting ferroptosis via activation of the Nrf2-SLC7A11-GPX4 pathway
- 8 August 2023
- Published by Elsevier in Chemosphere
- Vol. 339, 139716
Low-dose antimony exposure promotes prostate cancer proliferation by inhibiting ferroptosis via activation of the Nrf2-SLC7A11-GPX4 pathway
- Open Access
- 1 January 2022
- Published by Wiley in Journal of Nanomaterials
- Vol. 2022 (1)
Advances in Peripheral Nerve Injury Repair with the Application of Nanomaterials
Peripheral nerve injury (PNI) is a relatively common disease caused by various circumstances, ultimately affecting the life quality of patients. Although existing medications and surgical interventions have particular benefits for nerve repair, more effective therapeutic strategies are urgently needed for various types of nerve injuries. Increasing investigations of nanomaterials have demonstrated their excellent biological properties, such as biocompatibility, permeability, degradability, high medicine loading efficacy, suitable mechanical properties, and broad applications in the biomedical field. Concerning peripheral nerve (PN) repair, nanomaterials with outstanding biological properties can be fitted as nerve conduits to provide support and guidance for PN regeneration and loaded with functional cells, cytokines, or specific medications to promote regenerative outcomes further. Almost all existing studies have focused on the application of different nanomaterials in PN repair, while the application of nanomaterials in different PN injuries has not been taken into account. This article outlines the application of nanomaterials in the medical field and the prevalent therapeutic strategies for PN repair. Importantly, it focuses on the application of nanomaterials in various PNI diseases, covering injuries of the sciatic nerve, cavernous nerve, facial nerve, median nerve, and more.
- 1 January 2022
- Published by Wiley in Journal of Nanomaterials
- Vol. 2022 (1)
Open AccessAdvances in Peripheral Nerve Injury Repair with the Application of Nanomaterials
Peripheral nerve injury (PNI) is a relatively common disease caused by various circumstances, ultimately affecting the life quality of patients. Although existing medications and surgical interventions have particular benefits for nerve repair, more effective therapeutic strategies are urgently needed for various types of nerve injuries. Increasing investigations of nanomaterials have demonstrated their excellent biological properties, such as biocompatibility, permeability, degradability, high medicine loading efficacy, suitable mechanical properties, and broad applications in the biomedical field. Concerning peripheral nerve (PN) repair, nanomaterials with outstanding biological properties can be fitted as nerve conduits to provide support and guidance for PN regeneration and loaded with functional cells, cytokines, or specific medications to promote regenerative outcomes further. Almost all existing studies have focused on the application of different nanomaterials in PN repair, while the application of nanomaterials in different PN injuries has not been taken into account. This article outlines the application of nanomaterials in the medical field and the prevalent therapeutic strategies for PN repair. Importantly, it focuses on the application of nanomaterials in various PNI diseases, covering injuries of the sciatic nerve, cavernous nerve, facial nerve, median nerve, and more.